Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Intervention With the Glucagon-like Peptide 1 (GLP-1) Analog Liraglutide Plus Metformin Versus Metformin Monotherapy in Overweight/Obese Women With Metabolic Defects and Recent History of Gestational Diabetes Mellitus (GDM)

NCT01234649 is registered in ClinicalTrials.gov with Woman's as lead sponsor.

NCT NCT01234649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01234649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Intervention With the Glucagon-like Peptide 1 (GLP-1) Analog Liraglutide Plus Metformin Versus Metformin Monotherapy in Overweight/Obese Women With Metabolic Defects and Recent History of Gestational Diabetes Mellitus (GDM)
Lead sponsor
Woman's
Phase
Phase 3
Overall status
Completed
Start date
August 11, 2011
Completion date
June 14, 2019
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder of glucose regulation, gestational diabetes mellitus, impaired glucose tolerance, metabolic syndrome, type 2 diabetes mellitus